Skip to main content
CSL Ltd. logo

CSL Ltd. — Investor Relations & Filings

Ticker · CSL ISIN · AU000000CSL8 LEI · 529900ECSECK5ZDQTE14 ASX Manufacturing
Open in API
Filings indexed 2,555 across all filing types
Latest filing 2010-12-16 Director's Dealing
Country AU Australia
Listing ASX CSL

About CSL Ltd.

https://www.csl.com/

CSL is a global biotechnology company that researches, develops, manufactures, and markets a diverse portfolio of medicines. The company operates through distinct business units. CSL Behring provides plasma-derived and recombinant biotherapies for patients with rare and serious diseases, including bleeding disorders, immunodeficiencies, and neurological disorders. CSL Seqirus is a leading provider of vaccines, with a focus on influenza prevention and public health. CSL Vifor specializes in therapies for iron deficiency and nephrology, addressing the full spectrum of kidney disease. Collectively, CSL delivers lifesaving and life-enhancing treatments to a global patient population.

Recent filings

Filing Released Lang Actions
Change of Director`s Interest Notice 3 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings of a company director, including shares, performance rights, and options, with dates and transaction details. This is a regulatory disclosure of insider transactions by a director, not a financial report or announcement of a meeting or dividend. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives (insider trades). The document length is under 5,000 characters and contains detailed transaction data, confirming it is not a mere announcement but the actual notice of director's interest change.
2010-12-16 English
Appendix 3B 7 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class and number of securities issued, issue price, purpose, and quotation application to the ASX. It references specific ASX rules and the Corporations Act, indicating it is a formal announcement related to capital raising or share issuance. The content is consistent with a regulatory filing announcing new share issues rather than a full financial report or earnings release. The document length is over 10,000 characters and contains detailed data about the securities issued, but it is not a financial report or management discussion. Therefore, the document fits the category of a Share Issue/Capital Change announcement.
2010-12-16 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 95% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and references ASX rules related to share buy-backs. It provides detailed information about the number of shares bought back, prices paid, compliance statements, and dates. The content is focused on reporting the company's share repurchase activity rather than announcing a new financing round or capital structure change. The document length is 2639 characters, which is relatively short but contains substantive data about share buy-back transactions. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. There is no indication that this is an announcement of a report or a regulatory filing, nor is it a full financial report or management discussion. Therefore, the correct classification is POS with high confidence.
2010-12-15 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It references ASX rules and is a formal notice of share repurchase activity. The content matches the description of a report on the company's transactions in its own shares (share repurchase/issuance). The document length is 2643 characters, which is consistent with a detailed notice rather than a brief announcement. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2010-12-14 English
Change of Directors Interest Notice 3 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings of a director, including number of shares, performance rights, and options before and after the change, as well as the nature of the change (grant of performance rights and options). The document is a formal notification of a director's personal share transactions. It does not contain financial performance data, management discussion, or other report content. The document length is 3861 characters, which is consistent with a notice rather than a full report. Therefore, this fits the definition of Director's Dealing (DIRS).
2010-12-09 English
Daily share buy-back notice - Appendix 3E 2 pages ?Kb
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E Daily share buy-back notice' and contains detailed information about the company's on-market share buy-back activity, including number of shares bought back, prices paid, and compliance statements. It references ASX rules and is a formal notice to the exchange about share repurchase activity. The document length is 2646 characters, which is relatively short but contains substantive data about share buy-back transactions. This matches the definition of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. It is not an announcement of a report or a regulatory filing, but a direct report of share repurchase activity.
2010-12-08 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.